Design, synthesis and


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 7 8 2021
Statut: ppublish

Résumé

Compounds combining dual inhibitory action against FAAH and cyclooxygenase (COX) may be potentially useful analgesics. Here, we describe a novel flurbiprofen analogue, N-(3-bromopyridin-2-yl)-2-(2-fluoro-(1,1'-biphenyl)-4-yl)propanamide (

Identifiants

pubmed: 33896320
doi: 10.1080/14756366.2021.1875459
pmc: PMC8079065
doi:

Substances chimiques

Amides 0
Analgesics 0
Enzyme Inhibitors 0
Flurbiprofen 5GRO578KLP
Cyclooxygenase 2 EC 1.14.99.1
Amidohydrolases EC 3.5.-
fatty-acid amide hydrolase EC 3.5.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-953

Références

Science. 2017 Jun 9;356(6342):1084-1087
pubmed: 28596366
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Science. 2002 Nov 29;298(5599):1793-6
pubmed: 12459591
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12820-4
pubmed: 18753625
Trends Pharmacol Sci. 2014 Jun;35(6):284-92
pubmed: 24684963
J Enzyme Inhib Med Chem. 2019 Dec;34(1):562-576
pubmed: 30688118
Pharmacol Res. 2013 Jan;67(1):94-109
pubmed: 23127915
Eur J Med Chem. 2003 May;38(5):513-8
pubmed: 12767601
Br J Pharmacol. 2014 Mar;171(6):1408-19
pubmed: 24102214
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Chem Biol. 2009 Apr 24;16(4):411-20
pubmed: 19389627
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):451-8
pubmed: 19839936
J Med Chem. 2013 Jan 10;56(1):201-9
pubmed: 23214511
Mol Pain. 2011 Jan 17;7:7
pubmed: 21241462
Bioorg Chem. 2020 Aug;101:104034
pubmed: 32599361
Pain. 2015 May;156(5):890-903
pubmed: 25719612
Eur J Med Chem. 2020 Feb 15;188:111953
pubmed: 31945644
BMJ. 2016 May 18;353:i2727
pubmed: 27193592
Annu Rev Biochem. 2005;74:411-32
pubmed: 15952893
J Biol Chem. 2018 Mar 2;293(9):3028-3038
pubmed: 29326169
FASEB J. 2015 Jun;29(6):2616-27
pubmed: 25757568
J Pharmacol Exp Ther. 2009 Apr;329(1):48-56
pubmed: 19118134
Antioxid Redox Signal. 2020 Nov 10;33(14):1003-1009
pubmed: 32064887
Pharmacol Toxicol. 1997 Feb;80(2):103-7
pubmed: 9060042
Pharmacol Res. 2016 Jan;103:279-91
pubmed: 26675718
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Pain Med. 2017 Dec 1;18(12):2388-2400
pubmed: 28383710
Neuropharmacology. 2017 Sep 15;124:105-120
pubmed: 28625720
Nat Med. 2003 Jan;9(1):76-81
pubmed: 12461523
Psychopharmacology (Berl). 2016 Jun;233(12):2265-75
pubmed: 27048155
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10819-24
pubmed: 12136125
Sci Rep. 2013;3:1389
pubmed: 23474808
Pharmacol Res. 2012 May;65(5):553-63
pubmed: 22420940
Cells. 2014 May 23;3(2):517-45
pubmed: 24861977
J Biochem Biophys Methods. 2004 Aug 31;60(2):171-7
pubmed: 15262451
Eur J Pharmacol. 2013 Nov 15;720(1-3):383-90
pubmed: 24120370
Pain. 2012 Sep;153(9):1837-1846
pubmed: 22727500
Br J Pharmacol. 2006 May;148(1):102-13
pubmed: 16501580
Neurogastroenterol Motil. 2015 Jul;27(7):936-44
pubmed: 25869205
Eur J Pharmacol. 2007 Jun 22;565(1-3):26-36
pubmed: 17397826
J Med Chem. 2010 Mar 11;53(5):2286-98
pubmed: 20143779
Nat Chem Biol. 2011 Nov;7(11):803-9
pubmed: 22053353
Biochemistry. 2010 Aug 24;49(33):7069-79
pubmed: 20669977
J Med Chem. 2012 Oct 25;55(20):8807-26
pubmed: 23043222
Bioorg Chem. 2019 Aug;89:103007
pubmed: 31132600
PLoS One. 2015 Nov 13;10(11):e0142711
pubmed: 26565710
J Neurosci. 2012 May 16;32(20):7091-101
pubmed: 22593077
Nat Neurosci. 2010 Sep;13(9):1113-9
pubmed: 20729846
J Mol Graph Model. 2006 Oct;25(2):247-60
pubmed: 16458552
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2492-6
pubmed: 21392988
J Chem Inf Model. 2014 Feb 24;54(2):470-80
pubmed: 24437446
Biochem Pharmacol. 1993 Sep 1;46(5):791-6
pubmed: 8373432
Urology. 2017 May;103:191-197
pubmed: 28254462
J Biol Chem. 1993 Mar 25;268(9):6610-4
pubmed: 8454631
AAPS J. 2009 Jun;11(2):342-52
pubmed: 19430909
J Enzyme Inhib Med Chem. 2013 Feb;28(1):172-82
pubmed: 22225576
Arch Biochem Biophys. 1999 Feb 15;362(2):191-6
pubmed: 9989926

Auteurs

Alessandro Deplano (A)

Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy.

Jessica Karlsson (J)

Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.

Federica Moraca (F)

Department of Pharmacy, University of Naples Federico II, Naples, Italy.
Net4Science srl, University "Magna Graecia", Catanzaro, Italy.

Mona Svensson (M)

Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.

Claudia Cristiano (C)

Department of Pharmacy, University of Naples Federico II, Naples, Italy.

Carmine Marco Morgillo (CM)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK.

Christopher J Fowler (CJ)

Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.

Roberto Russo (R)

Department of Pharmacy, University of Naples Federico II, Naples, Italy.

Bruno Catalanotti (B)

Department of Pharmacy, University of Naples Federico II, Naples, Italy.

Valentina Onnis (V)

Unit of Pharmaceutical, Pharmacological and Nutraceutical Sciences, Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH